BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7935819)

  • 1. Promoter-specific imprinting of the human insulin-like growth factor-II gene.
    Vu TH; Hoffman AR
    Nature; 1994 Oct; 371(6499):714-7. PubMed ID: 7935819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
    Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
    J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues.
    Wu HK; Squire JA; Song Q; Weksberg R
    Biochem Biophys Res Commun; 1997 Apr; 233(1):221-6. PubMed ID: 9144427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
    Li Y; Meng G; Huang L; Guo QN
    Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin structure and imprinting: developmental control of DNase-I sensitivity in the mouse insulin-like growth factor 2 gene.
    Feil R; Handel MA; Allen ND; Reik W
    Dev Genet; 1995; 17(3):240-52. PubMed ID: 8565330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
    Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
    Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour.
    Taniguchi T; Schofield AE; Scarlett JL; Morison IM; Sullivan MJ; Reeve AE
    Oncogene; 1995 Aug; 11(4):751-6. PubMed ID: 7651739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma.
    Uchida K; Kondo M; Takeda S; Osada H; Takahashi T; Nakao A; Takahashi T
    Mol Carcinog; 1997 Apr; 18(4):193-8. PubMed ID: 9142213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human insulin-like growth factor-II promoter P1 is not restricted to liver: evidence for expression of P1 in other tissues and for a homologous promoter in baboon liver.
    Jin IH; Sinha G; Yballe C; Vu TH; Hoffman AR
    Horm Metab Res; 1995 Oct; 27(10):447-9. PubMed ID: 8575722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH; Chuyen NV; Li T; Hoffman AR
    Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic imprinting in the rat: linkage of Igf2 and H19 genes and opposite parental allele-specific expression during embryogenesis.
    Overall M; Bakker M; Spencer J; Parker N; Smith P; Dziadek M
    Genomics; 1997 Oct; 45(2):416-20. PubMed ID: 9344669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental regulation of genomic imprinting of the IGF2 gene in human liver.
    Davies SM
    Cancer Res; 1994 May; 54(10):2560-2. PubMed ID: 8168079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM
    Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic imprinting of IGF2, p57(KIP2) and PEG1/MEST in a marsupial, the tammar wallaby.
    Suzuki S; Renfree MB; Pask AJ; Shaw G; Kobayashi S; Kohda T; Kaneko-Ishino T; Ishino F
    Mech Dev; 2005 Feb; 122(2):213-22. PubMed ID: 15652708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
    Wu HK; Squire JA; Catzavelos CG; Weksberg R
    Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia.
    Wu HK; Weksberg R; Minden MD; Squire JA
    Biochem Biophys Res Commun; 1997 Feb; 231(2):466-72. PubMed ID: 9070302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development.
    Li X; Gray SG; Flam F; Pietsch T; Ekström TJ
    Int J Dev Biol; 1998 Jul; 42(5):687-93. PubMed ID: 9712523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
    Vu TH; Hoffman A
    J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin-like growth factor 2 imprinting status and promoter usage in the placenta of macrosomia].
    Yao JC; Hu YL; Wang ZQ; Dai YM; Ling JX; Ye XD
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):309-14. PubMed ID: 17673042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.